Product Information
GABAPENTIN 400 MG CAPSULE is a generic product labeled by Granules Pharmaceuticals Inc., priced at $0.0400 per EA under NDC 70010092801. Its NADAC has been published 109 times since Feb 1, 2023.
FDA first approved this application on Apr 6, 2005. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
400 mg/1
Manufacturer
Granules Pharmaceuticals Inc.NDC
70010092801
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
GABAPENTINApproval Type
Generic (ANDA)
FDA Application
ANDA075360FDA Approved
4/6/2005
TE Code
AB
On Market Since
9/1/2021
Pharmacological Classes
Price Statistics
The NADAC for GABAPENTIN 400 MG CAPSULE has been published 109 times since Feb 1, 2023, and over the history we have for it it has declined 27.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0400 per EA |
|---|---|
| All-time high | $0.0597 (May 10, 2023) |
| All-time low | $0.0396 (Apr 22, 2026) |
| 52-week high | $0.0445 |
| 52-week low | $0.0396 |
| Median price | $0.0438 |
| Average price | $0.0450 |
| Largest weekly change | -25.0% (Nov 20, 2024) |
| Weeks tracked | 109 |
| Tracking since | Feb 1, 2023 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of GABAPENTIN 400 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for GABAPENTIN 400 MG CAPSULE, manufactured by Granules Pharmaceuticals Inc., is $0.0400 per EA (NDC 70010092801), effective Aug 19, 2026.
How has the price of GABAPENTIN 400 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for GABAPENTIN 400 MG CAPSULE has declined 27.1%. It has been tracked across 109 weekly CMS publications since Feb 1, 2023.
What are the highest and lowest recorded NADAC prices for GABAPENTIN 400 MG CAPSULE?
Since Feb 1, 2023, the NADAC for GABAPENTIN 400 MG CAPSULE has ranged from a low of $0.0396 (Apr 22, 2026) to a high of $0.0597 (May 10, 2023), with a median of $0.0438 per EA.
Are there cheaper alternatives to GABAPENTIN 400 MG CAPSULE?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as GABAPENTIN 400 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures GABAPENTIN 400 MG CAPSULE?
GABAPENTIN 400 MG CAPSULE (NDC 70010092801) is labeled by Granules Pharmaceuticals Inc., and CMS classifies it as a generic product.